sequencing °Ë»ö°á°ú

100 °Ç (1/10 ÂÊ)
»ó¼¼Á¶°Ç    ÆÄÀÏÁ¾·ù 

[ÀÇÇÐ,¾àÇÐ] [ÀÇ»ý¸í°úÇÐ] Â÷¼¼´ë ¿°±â¼­¿­ ºÐ¼® - NGS(Next Generation Sequencing)¿¡ ´ëÇÏ¿©

[ÀÇÇÐ,¾àÇÐ] [ÀÇ»ý¸í°úÇÐ] Â÷¼¼´ë ¿°±â¼­¿­ ºÐ¼® - NGS(Next Generation Sequencing)¿¡ ´ëÇÏ¿©

¡¥º¯È­ ÃßÀÌ (http://www.genome.gov/sequencingcosts/) ¹Ì±¹ NIHÀÇ NHGRI¿¡¼­ Á¦°øÇÏ´Â Àΰ£ °Ô³ð ½ÃÄö½Ì ºñ¿ë º¯È­ ±×·¡ÇÁ¸¦ º¸ ¿©ÁÖ´Â »çÀÌÆ®. NGSÀÇ º»°ÝÀûÀÎ º¸±Þ°ú ÇÔ²² ¹«¾îÀÇ ¹ýÄ¢À» ´É °¡ÇÏ´Â ¼Óµµ·Î Çص¶ ºñ¿ëÀÌ °¨¼ÒµÇ°í ÀÖ´Â °ÍÀ» º¼ ¼ö ÀÖÀ¸¸ç ÀÌ ±×·¡ÇÁ´Â °è¼Ó °»½ÅµÇ°í ÀÖ´Ù. ÀÌ·¯ÇÑ Ãß¼¼¶ó¸é, °ð $1,000¿¡ °¡ ´ÉÇÏ°Ô µÉ °ÍÀ̶ó´Â Á¡ÀÌ ºÐ¸íÇÏ°Ô µå·¯³ª°í ÀÖ´Ù. NGSÀÇ µî¡¦
·¹Æ÷Æ® > ÀǾຸ°Ç   4page   1,200 ¿ø
[ÀÇÇÐ,¾àÇÐ]À¯ÀüÀÚ ºÐ¼® - sequencingÀ» ÀÌ¿ëÇÑ ADH¿Í ALDH2ÀÇ À¯ÀüÀÚÇü ºÐ¼®°ú polymorphism ¹ß±¼

[ÀÇÇÐ,¾àÇÐ]À¯ÀüÀÚ ºÐ¼® - sequencingÀ» ÀÌ¿ëÇÑ ADH¿Í ALDH2ÀÇ À¯ÀüÀÚÇü ºÐ¼®°ú polymorphism ¹ß±¼

[ÀÇÇÐ,¾àÇÐ]À¯ÀüÀÚ ºÐ¼® - sequencingÀ» ÀÌ¿ëÇÑ ADH¿Í ALDH2ÀÇ À¯ÀüÀÚÇü ºÐ¼®°ú polymorphism ¹ß±¼ / Abstract À̹ø ½ÇÇèÀº »ç¶÷ÀÇ DNA¿¡¼­ ƯÁ¤ À¯ÀüÀÚ(ADH, ALDH2)¿¡ ´ëÇÏ¿© À¯ÀüÀû ±â´ÉÀ» Ư¡Áþ´Â SNP¸¦ RFLP¸¦ ÅëÇØ È®ÀÎÇÏ°í sequencingÀ» ÅëÇØ Á¤È®ÇÑ sequence¸¦ ã¾Æ³»¾î ¿©·¯ sample DNAµéÀ» Data baseÀÇ reference¿Í ºñ±³ ºÐ¼®Çغ¸´Â ½ÇÇèÀ̾ú´Ù. ¸ÕÀú 18°³ÀÇ ÁغñµÈ sample DNA¡¦
·¹Æ÷Æ® > ÀǾຸ°Ç   9page   1,800 ¿ø
»ýÈ­ÇнÇÇè Sequencing (DNA ¿°±â¼­¿­ ºÐ¼®) ½ÇÇè º¸°í¼­ (ÇкΠ¼ö¼®ÀÇ ·¹Æ÷Æ® ½Ã¸®Áî)

»ýÈ­ÇнÇÇè Sequencing (DNA ¿°±â¼­¿­ ºÐ¼®) ½ÇÇè º¸°í¼­ (ÇкΠ¼ö¼®ÀÇ ·¹Æ÷Æ® ½Ã¸®Áî)

¡¥lasmid DNA extraction 2) DNA sequencing 3. Methods 1) Chemicals & Apparatus 2) Procedure 4. Data & Results 1) Restriction enzyme information 2) Insert cut information 3) vector cut information 4) Ligated plasmid refernce 5) Sequencing result (raw) 6) Edited sequencing result 7) Editing process 5. Discussion / [½æ³×ÀÏÀ» È®ÀÎÇØ ÁÖ¼¼¿ä]
·¹Æ÷Æ® > ÀÚ¿¬°úÇÐ   10page   1,000 ¿ø
[ÀÇÇÐ,¾àÇÐ]»ý¹°ÇÐ - Bioinformatics & Sequencing º¸°í¼­

[ÀÇÇÐ,¾àÇÐ]»ý¹°ÇÐ - Bioinformatics & Sequencing º¸°í¼­

[ÀÇÇÐ,¾àÇÐ]»ý¹°ÇÐ - Bioinformatics & Sequencing º¸°í¼­ / Bioinformatics & Sequencing 1. ½ÇÇè Á¦¸ñ Bioinformatics & Sequencing 2. ½ÇÇè¸ñÀû sequencing¿¡ ´ëÇØ ÀÌÇØÇÏ°í, sequencingÀ» ÅëÇØ ¾Ë ¼ö ÀÖ´Â DNA ¿°±â¼­¿­À» °¡Áö°í BLAST ºÐ¼®À» ÅëÇÏ¿© geneÀÇ ORF, homology, restriction enzyme site, motif, 2D structure µîÀ» ¾Ë¾Æº¸°í ÇÑ´Ù. 3. ½ÇÇè ¹æ¹ý ¨ç ½ÇÇè ¼ö¾÷ ½Ã°£¿¡¡¦
½ÇÇè°úÁ¦ > »ý¹°ÀÇ¾à   8page   1,800 ¿ø
DNA ¿°±â¼­¿­ ºÐ¼® (Sequencing)

DNA ¿°±â¼­¿­ ºÐ¼® (Sequencing)

¡¥±âº»ÀûÀÎ Á¤º¸¸¦ Á¦°øÇØÁÖ´Â Áß¿äÇÑ ½ÇÇèÀÌ´Ù. DNAÀÇ sequencingÀº 1977³â¿¡ À̸£·¯ °ÅÀÇ µ¿½Ã¿¡ °³¹ßµÈ µÎ °¡Áö ¹æ¹ý¿¡ ÀÇÇØ °¡´ÉÇÏ°Ô µÇ¾ú´Ù. ±× µÎ °¡Áö ¹æ¹ýÀº F. Sanger¿Í A. R. coulsonÀÌ °³¹ßÇÑ chain termination ¹æ¹ý°ú A. Maxam°ú W. GilbertÀÇ chemical degradation ¹æ¹ýÀÌ´Ù. ÇöÀç´Â ¿©·¯ °¡Áö ÀåÁ¡À¸·Î chain termination ¹æ¹ýÀ» ¼±È£ÇÏ°Ô µÇ¾ú´Ù. ±×·¡¼­ ¿©±â¼­´Â chain ¡¦
·¹Æ÷Æ® > °øÇбâ¼ú   2page   1,000 ¿ø
11ÁÖÂ÷ sequencing BL21 transformation

11ÁÖÂ÷ sequencing BL21 transformation

11ÁÖÂ÷ sequencing BL21 transformation / I.Purpose II.Theory 1. Sanger sequencing 2. Competent cell(BL21(DE3)) III.Apparatus/reagent IV.Procedure 1. Cloning ½ÇÇè ÀÌÈÄ (preculture) 2. Preculture ´ÙÀ½³¯ 3. 11ÁÖÂ÷ ½ÇÇè¼ö¾÷ ´çÀÏ V.Data&Results VI.Discussion / I.Purpose BL21 ¼¼±ÕÀº ´ëÀå±ÕÀÇ ÇÑ °è¿­·Î, ÀϹÝÀûÀ¸·Î ´Ü¹éÁú ¹ßÇö ½Ã½ºÅÛ¿¡¼­ ³Î¸® »ç¿ëµÈ¡¦
½ÇÇè°úÁ¦ > Àü±âÀüÀÚ   9page   3,000 ¿ø
11ÁÖÂ÷ sequencing BL21 transformation

11ÁÖÂ÷ sequencing BL21 transformation

11ÁÖÂ÷ sequencing BL21 transformation / I.Purpose II.Theory 1. Sanger sequencing 2. Competent cell(BL21(DE3)) III.Apparatus/reagent IV.Procedure 1. Cloning ½ÇÇè ÀÌÈÄ (preculture) 2. Preculture ´ÙÀ½³¯ 3. 11ÁÖÂ÷ ½ÇÇè¼ö¾÷ ´çÀÏ V.Data&Results VI.Discussion / I.Purpose 11ÁÖÂ÷ÀÇ BL21 º¯È¯ ½ÇÇèÀº ÁÖ·Î ´Ü¹éÁú ¹ßÇö ¹× Á¤Á¦¸¦ À§ÇÑ Áß¿äÇÑ °úÁ¤À¸·Î, ´ë¡¦
½ÇÇè°úÁ¦ > Àü±âÀüÀÚ   9page   3,000 ¿ø
Next Generation Sequencing(NGS) ºÐ¼® ±â±âÀÇ ±â¼úÇõ½ÅÀü·« ºÐ¼®-Illumina ±â¼úÇõ½ÅÀü·«

Next Generation Sequencing(NGS) ºÐ¼® ±â±âÀÇ ±â¼úÇõ½ÅÀü·« ºÐ¼®-Illumina ±â¼úÇõ½ÅÀü·«

Next Generation Sequencing(NGS) ºÐ¼® ±â±âÀÇ ±â¼úÇõ½ÅÀü·« ºÐ¼®-Illumina ±â¼úÇõ½ÅÀü·« / ¥°. ¼­·Ð 1. ¿°±â¼­¿­ ºÐ¼®¹ýÀÇ º¯È­ 2. ±â¾÷¼Ò°³ ¹× ¿¬±¸ ¸ñÀû ¥±. º»·Ð 1. IlluminaÀÇ ±â¼úÇõ½ÅÀü·« 2. °æÀï±â¾÷(1) - Thermo Fisher Scientific Inc. 3. °æÀï±â¾÷(2) - Roche 4. ½ÃÀå Àü¹Ý ºÐ¼® ¥². °á·Ð ¥³. Reference / ¥°. ¼­·Ð Next Generation Sequencing(NGS) ±â¼úÀº »ý¡¦
·¹Æ÷Æ® > °æ¿µ°æÁ¦   9page   3,000 ¿ø
PlasmidDNA Purification , Sanger Sequencing ·¹Æ÷Æ®

PlasmidDNA Purification , Sanger Sequencing ·¹Æ÷Æ®

PlasmidDNA Purification , Sanger Sequencing ·¹Æ÷Æ® / 1. ½ÇÇè ¹è°æ 1-1 Bacterial transformation 1-2 Liquid LB culture ¹× Colony Inoculation 1-3 Plasmid purification 1-4 »ç¿ëÇÏ´Â BufferÀÇ Á¾·ù ¹× ¿ªÇÒ 1-5 Sanger Sequencing 1-6 Sequence È®ÀÎ ¹× Blast ÇÁ·Î±×·¥ 2. ½ÇÇè ¸ñÀû ¹× ¹æ¹ý - 2-1 ½ÇÇè ¸ñÀû 2-2 ½ÇÇè ¹æ¹ý 3. ½ÇÇè °á°ú 3-1 Chromas¸¦ ÅëÇÑ se¡¦
·¹Æ÷Æ® > ÀÚ¿¬°úÇÐ   11page   3,000 ¿ø
[A0] ¼­°­´ë Çö´ë»ý¹°ÇнÇÇè2 4Â÷ Ç®·¹Æ÷Æ® - GFPuv¸¦ ÀÌ¿ëÇÑ Site-directed mutagenesisÀÇ ½Ç½À°ú DNA sequencing °á°úÀÇ ºÐ¼® ¿¬½À

[A0] ¼­°­´ë Çö´ë»ý¹°ÇнÇÇè2 4Â÷ Ç®·¹Æ÷Æ® - GFPuv¸¦ ÀÌ¿ëÇÑ Site-directed mutagenesisÀÇ ½Ç½À°ú DNA sequencing °á°úÀÇ ºÐ¼® ¿¬½À

[A0] ¼­°­´ë Çö´ë»ý¹°ÇнÇÇè2 4Â÷ Ç®·¹Æ÷Æ® - GFPuv¸¦ ÀÌ¿ëÇÑ Site-directed mutagenesisÀÇ ½Ç½À°ú DNA sequencing °á°úÀÇ ºÐ¼® ¿¬½À / 1. Abstract 2. Introduction 3. Materials & Method 4. Result 5. Discussion 6. Reference / 1. Abstract º» ½ÇÇèÀº GFPuv(Çü±¤ ´Ü¹éÁú)¸¦ ÀÌ¿ëÇÑ site-directed mutagenesis ±â¹ýÀ» Àû¿ëÇÏ¿© ƯÁ¤ À¯ÀüÀÚÀÇ º¯À̸¦ À¯µµÇÏ°í, ÀÌÀÇ ¼­¿­ ºÐ¡¦
·¹Æ÷Æ® > ÀÚ¿¬°úÇÐ   5page   3,000 ¿ø




ȸ»ç¼Ò°³ | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æħ | °í°´¼¾ÅÍ ¤Ó olle@olleSoft.co.kr
¿Ã·¹¼ÒÇÁÆ® | »ç¾÷ÀÚ : 408-04-51642 ¤Ó ±¤ÁÖ±¤¿ª½Ã ±¤»ê±¸ ¹«Áø´ë·Î 326-6, 201È£ | äÈñÁØ | Åë½Å : ±¤»ê0561È£
Copyright¨Ï ¿Ã·¹¼ÒÇÁÆ® All rights reserved | Tel.070-8744-9518
ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æħ ¤Ó °í°´¼¾ÅÍ ¤Ó olle@olleSoft.co.kr
¿Ã·¹¼ÒÇÁÆ® | »ç¾÷ÀÚ : 408-04-51642 | Tel.070-8744-9518